Cannabis

Department of Health and Social Care written question – answered on 4th July 2019.

Alert me about debates like this

Photo of Paul Farrelly Paul Farrelly Labour, Newcastle-under-Lyme

To ask the Secretary of State for Health and Social Care, what steps he is taking to regulate the cannabidiol market; and whether he plans to create a new medical model for the (a) tetrahydrocannabinol and (b) cannabidiol sectors.

Photo of Seema Kennedy Seema Kennedy The Parliamentary Under-Secretary for Health and Social Care

Given that cannabidiol extracts are found in many products and not just in food, Departmental officials are also working with other Government departments to assess all the relevant issues. We will consider evidence to develop the most suitable approach for regulation and compliance. The Food Standards Agency (FSA) will continue to engage with stakeholders on how the Government can achieve this.

On 1 November 2018, the Government changed the law to enable specialist doctors to prescribe cannabis-based products for medicinal use. This includes products containing tetrahydrocannabinol and cannabidiol. The regulations use the existing regulatory frameworks for medicines and the misuse of controlled drugs, an approach which the Government believes is proportionate and evidence-based, ensuring that clinicians can access these products whilst minimising the risk of misuse, harm and diversion.

The Food Standards Agency (FSA) has been working with local authorities, businesses, consumers and other stakeholders to determine how to regulate the cannabidiol market and achieve compliance in a proportionate manner.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.